Femasys (NASDAQ:FEMY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They presently have a $12.00 price target on the stock. Separately, Chardan Capital cut their price target on Femasys from $10.00 to $8.00 and set a “buy” rating for the […]

Shares of Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) have been assigned an average rating of “Buy” from the eight brokerages that are currently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 […]

Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued on Tuesday,Benzinga reports. They currently have a $30.00 price target on the stock. Olema Pharmaceuticals Price Performance NASDAQ:OLMA opened at $4.51 on Tuesday. Olema Pharmaceuticals has a fifty-two week low of $3.95 and a […]

electroCore (NASDAQ:ECOR – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a note issued to investors on Thursday,Benzinga reports. They currently have a $25.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 92.31% from the company’s current price. electroCore Trading […]

ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at D. Boral Capital in a research note issued to investors on Thursday,Benzinga reports. They currently have a $30.00 price target on the stock. A number of other research analysts also recently weighed in on IBRX. HC Wainwright assumed coverage […]

Equities research analysts at Citigroup initiated coverage on shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Free Report) in a report issued on Thursday,Briefing.com Automated Import reports. The brokerage set a “buy” rating and a $40.00 price target on the stock. Citigroup’s price objective indicates a potential upside of 77.78% from the company’s previous close. Separately, […]

Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have been given a consensus rating of “Buy” by the five brokerages that are covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have updated their coverage on the stock […]

Shares of Aritzia Inc. (TSE:ATZ – Get Free Report) have received an average recommendation of “Moderate Buy” from the eight analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target […]

Freshworks Inc. (NASDAQ:FRSH – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to […]

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received an average rating of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1 year target […]